Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.0 SEK
22.70 M SEK
264.17 M SEK
11.82 M
About EQL PHARMA AB
Sector
CEO
Axel Schörling
Headquarters
Lund
Website
Founded
2006
ISIN
SE0005497732
FIGI
BBG005HH07P9
EQL Pharma AB engages in the manufacture, development and distribution of generic and specialty pharmaceutical products. It offers medicines to pharmacies and hospitals in the Nordic region. The company was founded by Karin Wehlin and Lars Christer Fedrik Fåhræus in 2006 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EQL is 78.8 SEK — it has decreased by −2.51% in the past 24 hours. Watch EQL PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange EQL PHARMA AB stocks are traded under the ticker EQL.
EQL stock has fallen by −2.02% compared to the previous week, the month change is a 11.78% rise, over the last year EQL PHARMA AB has showed a 140.98% increase.
EQL stock is 2.60% volatile and has beta coefficient of −0.25. Track EQL PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is EQL PHARMA AB there?
Today EQL PHARMA AB has the market capitalization of 2.26 B, it has decreased by −1.24% over the last week.
Yes, you can track EQL PHARMA AB financials in yearly and quarterly reports right on TradingView.
EQL PHARMA AB is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
EQL earnings for the last quarter are 0.33 SEK per share, whereas the estimation was 0.22 SEK resulting in a 50.00% surprise. The estimated earnings for the next quarter are 0.46 SEK per share. See more details about EQL PHARMA AB earnings.
EQL PHARMA AB revenue for the last quarter amounts to 85.10 M SEK, despite the estimated figure of 85.00 M SEK. In the next quarter, revenue is expected to reach 94.50 M SEK.
EQL net income for the last quarter is 9.56 M SEK, while the quarter before that showed 10.41 M SEK of net income which accounts for −8.16% change. Track more EQL PHARMA AB financial stats to get the full picture.
No, EQL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 21.00 employees. See our rating of the largest employees — is EQL PHARMA AB on this list?
Like other stocks, EQL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EQL PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EQL PHARMA AB technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EQL PHARMA AB stock shows the buy signal. See more of EQL PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.